New product [Regulatives / Guidelines]

posted by ping4santosh  – India, 2020-03-11 16:34 (404 d 04:02 ago) – Posting: # 21256
Views: 3,326

» » Both the APIs are registered as individual products in market and we are just combining both. Why would you call it as a new product [...]
»
» Because that's what it is. You have to distinguish API and formulation. This will be a new combination of two existing API.

Dear Ohlbe,

Both the APIs are registered and marketed as separate formulation. We are mixing these two at same ratio into one formulation without adding any new excipients. I don't know why will it be considered as a new product. Can you guide me please?


Edit: Please don’t shout[Helmut]

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 21 (0 registered, 21 guests [including 2 identified bots]).
Forum time: Monday 21:36 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5